Moyamoya disorder in the United States

Neurosurgery

Volumn 71, Issue 1, 2012, Pages 93-99

  Starke, Robert M ^a   Crowley, R Webster ^a   Maltenfort, Mitchell ^b   Jabbour, Pascal M ^b   Gonzalez, L Fernando ^b   Tjoumakaris, Stavropoula I ^b   Randazzo, Ciro G ^b   Rosenwasser, Robert H ^b   Dumont, Aaron S ^b  

^a UNIVERSITY OF VIRGINIA   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Bypass; Hemorrhage; Moyamoya; National; National inpatient sample; Nationwide hospitalization; Outcomes; Stroke

Indexed keywords

ADULT; ARTICLE; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; COMORBIDITY; DISEASE ASSOCIATION; EXTRAINTRACRANIAL ANASTOMOSIS; FEMALE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HOME CARE; HOSPITAL; HOSPITAL ADMISSION; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MOYAMOYA DISEASE; OUTCOME ASSESSMENT; PHENOTYPE; PRIORITY JOURNAL; SEX DIFFERENCE; UNITED STATES;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; LENGTH OF STAY; MALE; MIDDLE AGED; MOYAMOYA DISEASE; PREDICTIVE VALUE OF TESTS; TREATMENT OUTCOME; UNITED STATES; YOUNG ADULT;

EID: 84862898033     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1227/NEU.0b013e318253ab8e     Document Type: Article

References (26)

1. Baba T, Houkin K, Kuroda S. Novel epidemiological features of moyamoya disease. J Neurol Neurosurg Psychiatry. 2008;79(8):900-904.
2. Fukui M. Guidelines for the diagnosis and treatment of spontaneous occlusion of the circle of Willis ('moyamoya' disease). Research Committee on Spontaneous Occlusion of the Circle of Willis (Moyamoya Disease) of the Ministry of Health and Welfare, Japan. Clin Neurol Neurosurg. 1997;99(suppl 2):S238-S240.
3. Kuroda S, Houkin K. Moyamoya disease: current concepts and future perspectives. Lancet Neurol. 2008;7(11):1056-1066.
4. Nishimoto A. [Moyamoya disease (author's transl)]. Neurol Med Chir (Tokyo). 1979;19(3):221-228.
5. Saeki N, Yamaura A, Hoshi S, Sunami K, Ishige N, Hosoi Y. [Hemorrhagic type of moyamoya disease]. No Shinkei Geka. 1991;19(8):705-712.
6. Hallemeier CL, Rich KM, Grubb RL Jr, et al. Clinical features and outcome in North American adults with moyamoya phenomenon. Stroke. 2006;37(6):1490- 1496. (Pubitemid 44305731)
7. Chiu D, Shedden P, Bratina P, Grotta JC. Clinical features of moyamoya disease in the United States. Stroke. 1998;29(7):1347-1351. (Pubitemid 28300068)
8. Festa JR, Schwarz LR, Pliskin N, et al. Neurocognitive dysfunction in adult moyamoya disease. J Neurol. 2010;257(5):806-815.
9. Starke RM, Komotar RJ, Hickman ZL, et al. Clinical features, surgical treatment, and long-term outcome in adult patients with moyamoya disease. Clinical article. J Neurosurg. 2009;111(5):936-942.
10. Mesiwala AH, Sviri G, Fatemi N, Britz GW, Newell DW. Long-term outcome of superficial temporal artery-middle cerebral artery bypass for patients with moyamoya disease in the US. Neurosurg Focus. 2008;24(2):E15.
11. Kraemer M, Heienbrok W, Berlit P. Moyamoya disease in Europeans. Stroke. 2008;39(12):3193-3200.
12. Lee S, Lee S, Kim S, Pokorski R. Moyamoya disease: review of the literature and estimation of excess morbidity and mortality. J Insur Med. 2009;41(3):207-212.
13. Burke GM, Burke AM, Sherma AK, Hurley MC, Batjer HH, Bendok BR. Moyamoya disease: a summary. Neurosurg Focus. 2009;26(4):E11.
14. Andaluz N, Choutka O, Zuccarello M. Trends in the management of adult moyamoya disease in the United States: results of a nationwide survey. World Neurosurg. 2010;73(4):361-364.
15. Khan N, Schuknecht B, Boltshauser E, et al. Moyamoya disease and Moyamoya syndrome: experience in Europe; choice of revascularisation procedures. Acta Neurochir (Wien). 2003;145(12):1061-1071; discussion 1071.
16. Uchino K, Johnston SC, Becker KJ, Tirschwell DL. Moyamoya disease in Washington State and California. Neurology. 2005;65(6):956-958. (Pubitemid 41362154)
17. Lee DJ, Liebeskind DS. Characterization of inpatient moyamoya in the United States: 1988-2004. Front Neurol. 2011;2:43.
18. Kuriyama S, Kusaka Y, Fujimura M, et al. Prevalence and clinicoepidemiological features of moyamoya disease in Japan: findings from a nationwide epidemiological survey. Stroke. 2008;39(1):42-47.
19. Ikezaki K, Han DH, Kawano T, Kinukawa N, Fukui M. A clinical comparison of definite moyamoya disease between South Korea and Japan. Stroke. 1997;28(12):2513-2517. (Pubitemid 28007660)
20. Ueki K, Meyer FB, Mellinger JF. Moyamoya disease: the disorder and surgical treatment. Mayo Clin Proc. 1994;69(8):749-757. (Pubitemid 24238075)
21. Houkin K, Ishikawa T, Yoshimoto T, Abe H. Direct and indirect revascularization for moyamoya disease surgical techniques and peri-operative complications. Clin Neurol Neurosurg. 1997;99(suppl 2):S142-S145. (Pubitemid 27489083)
22. Roach ES, Golomb MR, Adams R, et al. Management of stroke in infants and children: a scientific statement from a Special Writing Group of the American Heart Association Stroke Council and the Council on Cardiovascular Disease in the Young. Stroke. 2008;39(9):2644-2691.
23. Sacco RL, Adams R, Albers G, et al. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guideline. Stroke. 2006;37(2):577-617. (Pubitemid 43732031)
24. Broderick J, Connolly S, Feldmann E, et al. Guidelines for the management of spontaneous intracerebral hemorrhage in adults: 2007 update: a guideline from the American Heart Association/American Stroke Association Stroke Council, High Blood Pressure Research Council, and the Quality of Care and Outcomes in Research Interdisciplinary Working Group. Stroke. 2007;38(6):2001-2023. (Pubitemid 46850654)
25. Guzman R, Lee M, Achrol A, et al. Clinical outcome after 450 revascularization procedures for moyamoya disease. Clinical article. J Neurosurg. 2009;111(5):927-935.
26. Starke RM, Komotar RJ, Connolly ES. Optimal surgical treatment for moyamoya disease in adults: direct versus indirect bypass. Neurosurg Focus. 2009;26(4):E8.